Bio-Techne Cp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 285,442 | 263,099 | 139,585 | 229,296 | 96,072 |
| Depreciation Amortization | 107,238 | 101,069 | 87,747 | 82,737 | 78,171 |
| Income taxes - deferred | -29,567 | 6,816 | -27,431 | 13,130 | -13,582 |
| Accounts receivable | -20,867 | -57,596 | -15,549 | 6,556 | -15,000 |
| Accounts payable and accrued liabilities | -7,908 | 12,741 | 19,091 | 10,343 | 6,101 |
| Other Working Capital | -90,577 | -69,517 | 29,263 | -5,246 | -27,751 |
| Other Operating Activity | 10,632 | 68,660 | 119,458 | -131,599 | 57,608 |
| Operating Cash Flow | $254,393 | $325,272 | $352,164 | $205,217 | $181,619 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,736 | -26,943 | 26,693 | 76,933 | -21,896 |
| PPE Investments | -38,244 | -44,908 | -44,301 | -51,744 | -25,411 |
| Net Acquisitions | -101,184 | N/A | -225,352 | N/A | -289,492 |
| Purchase Of Investment | -232,000 | -25,000 | -556 | 1,906 | N/A |
| Sale Of Investment | 91,043 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-265,649 | $-96,851 | $-243,516 | $27,095 | $-336,799 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 619,661 | 90,000 | 256,000 | 40,000 | 580,000 |
| Debt Repayment | -525,661 | -175,500 | -271,500 | N/A | N/A |
| Common Stock Issued | 29,813 | 77,155 | 65,092 | 70,983 | 37,950 |
| Common Stock Repurchased | -19,562 | -160,950 | -43,178 | -50,112 | -15,405 |
| Dividend Paid | -50,285 | -50,185 | -49,622 | -48,902 | -48,364 |
| Other Financing Activity | -31,350 | -23,373 | -19,343 | -195,771 | -419,797 |
| Financing Cash Flow | $22,616 | $-242,853 | $-62,551 | $-183,802 | $134,384 |
| Exchange Rate Effect | -3,356 | -12,092 | 6,369 | -2,771 | -308 |
| Beginning Cash Position | 172,567 | 199,091 | 146,625 | 100,886 | 121,990 |
| End Cash Position | 180,571 | 172,567 | 199,091 | 146,625 | 100,886 |
| Net Cash Flow | $8,004 | $-26,524 | $52,466 | $45,739 | $-21,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | 254,393 | 325,272 | 352,164 | 205,217 | 181,619 |
| Capital Expenditure | -38,244 | -44,908 | -44,301 | -51,744 | -25,411 |
| Free Cash Flow | 216,149 | 280,364 | 307,863 | 153,473 | 156,208 |